Fundz

Air Nexis Therapeutics reported raising $62 Million in an initial SEC Form D filing, from an offering of $200 Million

PRIVATEMar 09, 2026$62M of $200M raised

Amount Raised

$62 Million

$62 Million sold, per SEC Form D (first sale Jan 9, 2026)

Round Type

Venture

Palo AltoBiotechnologyHealth CareTherapeutics

Quick answer

AirNexis Therapeutics raised $62 Million in a funding round, dated January 9, 2026. AirNexis Therapeutics is based in Palo Alto, California, United States.

How much did AirNexis Therapeutics raise?
AirNexis Therapeutics raised $62 Million in a funding round on January 9, 2026.
What does AirNexis Therapeutics do?
AirNexis Therapeutics is a clinical-stage biotech company developing novel therapeutic drugs for the treatment of COPD patients.
Where is AirNexis Therapeutics based and how big is it?
AirNexis Therapeutics is based in Palo Alto, California, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as AirNexis Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Altesa raised $75M (Series B) on February 19, 2026.
  • Lario Therapeutics raised $2.4M (Grant) on February 19, 2026.
  • Korsana Biosciences raised $175M (Series A) on February 18, 2026.
  • Faeth Therapeutics raised $200M (Post-IPO Equity) on February 18, 2026.
  • Sift Biosciences raised $3.7M (Pre-Seed) on February 18, 2026.
  • Brainstorm Cell Therapeutics raised $1M (Post-IPO Equity) on February 13, 2026.

Who to call at AirNexis Therapeutics, and when

A new round usually means AirNexis Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day AirNexis Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AirNexis Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AirNexis Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AirNexis Therapeutics

Location

Palo Alto, California, United States

About

AirNexis Therapeutics is a clinical-stage biotech company developing novel therapeutic drugs for the treatment of COPD patients. AN01 is a dual PDE3/4 inhibitor that exerts synergistic effects through a dual mechanism of action that promotes bronchodilation and reduces the release of inflammatory factors.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AirNexis Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for AirNexis Therapeutics's next move

See what Strategic adds

AirNexis Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.